It's time to phase out “serologic weak D phenotype” and resolve D types with RHD genotyping including weak D type 4-Reference-Cited by-同舟云学术

It's time to phase out “serologic weak D phenotype” and resolve D types with RHD genotyping including weak D type 4

Published:2020-03-12 Issue:4 Volume:60 Page:855-859
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Flegel Willy A.¹²^ORCID,Denomme Gregory A.³^ORCID,Queenan John T.⁴,Johnson Susan T.⁵,Keller Margaret A.⁶,Westhoff Connie M.⁷^ORCID,Katz Louis M.⁸,Delaney Meghan⁹,Vassallo Ralph R.¹⁰,Simon Clayton D.¹¹,Sandler S. Gerald¹

Affiliation:

1. Department of Pathology and Laboratory MedicineMedStar Georgetown University Hospital Washington, DC USA

2. Department of Transfusion Medicine, NIH Clinical CenterNational Institutes of Health Bethesda Maryland USA

3. Diagnostic LaboratoriesVersiti Milwaukee Wisconsin USA

4. Department of Obstetrics and GynecologyMedStar Georgetown University Hospital Washington, DC USA

5. Clinical EducationVersiti Milwaukee Wisconsin USA

6. National Molecular LaboratoryAmerican Red Cross Biomedical Services Philadelphia Pennsylvania USA

7. Laboratory of Immunohematology and GenomicsNew York Blood Center Enterprises New York New York USA

8. Mississippi Valley Regional Blood Center Davenport Iowa USA

9. Childrenʼs National Medical Center Washington, DC USA

10. Vitalant Scottsdale Arizona USA

11. Defense Health AgencyArmed Services Blood Program Office Falls Church Virginia USA

Funder

NIH Clinical Center

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15741

Reference51 articles.

1. AABB Statements. Joint statement on phasing‐in RHD genotyping for pregnant women and other females of childbearing potential with a serologic weak D phenotype. 2015 [cited 2019 May 5]. Available from:http://www.aabb.org/advocacy/statements/Pages/statement150722.aspx.

2. It's time to phase inRHDgenotyping for patients with a serologic weak D phenotype

3. A proposal to standardize terminology for weak D antigen

4. Significantly enhanced testing sensitivities of automated ORTHO VISION analyzers detect weak D phenotypes

5. Red cell genotyping precision medicine: a conference summary

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASIAN TYPE DEL: TESTS FOR RED CELLS AND MANAGEMENTS FOR RECIPIENTS, DONORS, AND PREGNANT/POTENTIAL CHILDBEARING WOMEN;Japanese Journal of Transfusion and Cell Therapy;2024-08-26

2. Blood group genotype matching for transfusion;British Journal of Haematology;2024-08-05

3. 40 years of researching the Del phenotype results in a change of transfusion practice;Transfusion;2024-06-20

4. Serologic profiling of D variants in donor routine: unveiling the impact on false-negative results and alloimmunization;Immunohematology;2024-06-01

5. Clinical Indications for RHD Genotyping in Koreans;The Korean Journal of Blood Transfusion;2024-04-30